Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1984 Apr;115(1):57–69.

Guinea pig macroalbumin. A major inhibitor of activated Hageman factor in plasma with an alpha 2-macroglobulin-like nature.

T Ishimatsu, T Yamamoto, K Kozono, T Kambara
PMCID: PMC1900347  PMID: 6201075

Abstract

A major inhibitor of the beta form of activated Hageman factor (beta-HFa) with an apparent molecular weight of 28,000, which was reported as a strong permeability factor (Yamamoto and Cochrane, Am J Pathol 1981, 105: 164-175), was purified from guinea pig plasma. When it was depleted in vitro, the plasma lost 71% of the total inhibitory activity toward beta-HFa. The inhibitor, termed "macroalbumin," with an apparent molecular weight of 720,000 and an apparent pI of 4.6, seemed to be an inhibitor similar to alpha 1- or alpha 2-macroglobulin of man and other mammalian species in physicochemical characteristics and in enzymologic properties. Though the inhibitory activity to beta-HFa was negligible in normal skin extract, a significant inhibitory activity appeared in extracts of permeability-enhanced skin sites which were induced by intradermal beta-HFa injection. The inhibitory activity that appeared was macroalbumin-dependent, with more than a 10-fold increase in the concentration. These results indicate the roles of macroalbumin as a negative feedback regulator in situ to the Hageman-factor-dependent pathway in a permeability enhancement system.

Full text

PDF
57

Images in this article

62Figure 4
on p.62
63Figure 5
on p.63

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armand Y. J., Guinand S. Composition et structure de L'alpha-2-macroglobuline isolée du serum de porc. Biochim Biophys Acta. 1967 Feb 21;133(2):289–300. [PubMed] [Google Scholar]
  2. Aukland K., Nicolaysen G. Interstitial fluid volume: local regulatory mechanisms. Physiol Rev. 1981 Jul;61(3):556–643. doi: 10.1152/physrev.1981.61.3.556. [DOI] [PubMed] [Google Scholar]
  3. Berne B. H., Dray S., Knight K. L. Contribution of the allelic mtz3 and Mtz4 allotype genes to the formation of individual rabbit serum alpha2 -macroglobulin molecules. Biochem Genet. 1972 Oct;7(2):95–110. doi: 10.1007/BF00486080. [DOI] [PubMed] [Google Scholar]
  4. Berne B. H., Dray S., Knight K. L. Immunological relationships of serum alpha-macroglobulins in the human, rat, and rabbit. Proc Soc Exp Biol Med. 1971 Nov;138(2):531–535. doi: 10.3181/00379727-138-35933. [DOI] [PubMed] [Google Scholar]
  5. Forbes C. D., Pensky J., Ratnoff O. D. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. J Lab Clin Med. 1970 Nov;76(5):809–815. [PubMed] [Google Scholar]
  6. Fujikawa K., Kurachi K., Davie E. W. Characterization of bovine factor XIIa (activated Hageman factor). Biochemistry. 1977 Sep 20;16(19):4182–4188. doi: 10.1021/bi00638a008. [DOI] [PubMed] [Google Scholar]
  7. Gauthier F., Genell S., Mouray H., Ohlsson K. The in vitro interactions of rat pancreatic elastase and normal and inflammatory ray serum. Biochim Biophys Acta. 1978 Sep 11;526(1):218–226. doi: 10.1016/0005-2744(78)90306-6. [DOI] [PubMed] [Google Scholar]
  8. Got R., Cheftel R. I., Font J., Moretti J. Etude de l'alpha-1-macroglobuline du serum de lapin. 3. Biochimie de la copule glucidique. Biochim Biophys Acta. 1967 Mar 22;136(2):320–330. [PubMed] [Google Scholar]
  9. Harpel P. C. Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure. J Exp Med. 1973 Sep 1;138(3):508–521. doi: 10.1084/jem.138.3.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hatcher V. B., Lazarus G. S., Levine N., Burk P. G., Yost F. J., Jr Characterization of a chemotactic and cytotoxic proteinase from human skin. Biochim Biophys Acta. 1977 Jul 8;483(1):160–171. doi: 10.1016/0005-2744(77)90018-3. [DOI] [PubMed] [Google Scholar]
  11. Howard J. B. Reactive site in human alpha 2-macroglobulin: circumstantial evidence for a thiolester. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2235–2239. doi: 10.1073/pnas.78.4.2235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hudson N. W., Koo P. H. Subunit and primary structure of a mouse alpha-macroglobulin, a human alpha 2-macroglobulin homologue. Biochim Biophys Acta. 1982 Jun 4;704(2):290–303. doi: 10.1016/0167-4838(82)90159-5. [DOI] [PubMed] [Google Scholar]
  13. Kambara T., Kawagoe T., Nakamura T. An alkaline proteinase which has inflammatory activity isolated from guinea pig lymphoid cells. Biochim Biophys Acta. 1982 May 27;716(2):224–231. doi: 10.1016/0304-4165(82)90272-0. [DOI] [PubMed] [Google Scholar]
  14. Kobayashi S., Nagasawa S. Protease inhibitors in guinea pig serum. I. Isolation of two functionally different trypsin inhibitors from guinea pig serum. Biochim Biophys Acta. 1974 Apr 11;342(2):372–381. doi: 10.1016/0005-2795(74)90093-2. [DOI] [PubMed] [Google Scholar]
  15. Kozono K., Yamamoto T., Kambara T. A proteaselike permeability factor in guinea pig skin: contact activation of the latent permeability factor and its nature as a prekallikrein activator. Am J Pathol. 1980 Sep;100(3):619–632. [PMC free article] [PubMed] [Google Scholar]
  16. Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
  17. Morita T., Kato H., Iwanaga S., Takada K., Kimura T. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase. J Biochem. 1977 Nov;82(5):1495–1498. doi: 10.1093/oxfordjournals.jbchem.a131840. [DOI] [PubMed] [Google Scholar]
  18. Nagasawa S., Sugihara H., Han B. H., Suzuki T. Studies on alpha 2-macroglobulin in bovine plasma. I. Purification, physical properties, and chemical compositions. J Biochem. 1970 Jun;67(6):809–819. doi: 10.1093/oxfordjournals.jbchem.a129313. [DOI] [PubMed] [Google Scholar]
  19. Nieuwenhuizen W., Emeis J. J., Hemmink J. Purification and properties of rat alpha 2 acute-phase macroglobulin. Biochim Biophys Acta. 1979 Sep 29;580(1):129–139. doi: 10.1016/0005-2795(79)90204-6. [DOI] [PubMed] [Google Scholar]
  20. ORNSTEIN L. DISC ELECTROPHORESIS. I. BACKGROUND AND THEORY. Ann N Y Acad Sci. 1964 Dec 28;121:321–349. doi: 10.1111/j.1749-6632.1964.tb14207.x. [DOI] [PubMed] [Google Scholar]
  21. Ohlsson K. Isolation and partial characterization of two related trypsin binding alpha-macroglobulins of dog plasma. Biochim Biophys Acta. 1971 Apr 27;236(1):84–91. doi: 10.1016/0005-2795(71)90153-x. [DOI] [PubMed] [Google Scholar]
  22. PICARD J. J., HEREMANS J. F. Studies on alpha2-macroblobulin. I. A method for the isolation of rabbit alpha2-macroglobulin. Biochim Biophys Acta. 1963 Jun 4;71:554–561. doi: 10.1016/0006-3002(63)91127-2. [DOI] [PubMed] [Google Scholar]
  23. Pepper D. S. The isolation and properties of gamma inhibitor: an equine alpha 2-macroglobulin sub-fraction. Biochim Biophys Acta. 1968 Mar 11;156(2):327–339. doi: 10.1016/0304-4165(68)90262-6. [DOI] [PubMed] [Google Scholar]
  24. SCHEIDEGGER J. J. Une micro-méthode de l'immuno-electrophorèse. Int Arch Allergy Appl Immunol. 1955;7(2):103–110. [PubMed] [Google Scholar]
  25. Saito H., Goldsmith G. H., Moroi M., Aoki N. Inhibitory spectrum of alpha 2-plasmin inhibitor. Proc Natl Acad Sci U S A. 1979 Apr;76(4):2013–2017. doi: 10.1073/pnas.76.4.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schapira M., Scott C. F., James A., Silver L. D., Kueppers F., James H. L., Colman R. W. High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors. Biochemistry. 1982 Feb 2;21(3):567–572. doi: 10.1021/bi00532a024. [DOI] [PubMed] [Google Scholar]
  27. Stone P. J., Calore J. D., Snider G. L., Franzblau C. Role of alpha-macroglobulin-elastase complexes in the pathogenesis of elastase-induced emphysema in hamsters. J Clin Invest. 1982 Apr;69(4):920–931. doi: 10.1172/JCI110531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Summaria L., Spitz F., Arzadon L., Boreisha I. G., Robbins K. C. Isolation and characterization of the affinity chromatography forms of human Glu- and Lys-plasminogens and plasmins. J Biol Chem. 1976 Jun 25;251(12):3693–3699. [PubMed] [Google Scholar]
  29. Swenson R. P., Howard J. B. Amino acid sequence of the tryptic peptide containing the alkylamine-reactive site from human alpha 2-macroglobulin. Identification of gamma-glutamylmethylamide. J Biol Chem. 1980 Sep 10;255(17):8087–8091. [PubMed] [Google Scholar]
  30. Takeuchi Y., Movat H. Z. Conversion of Hageman factor (factor XII) of the guinea pig to prekallikrein activator and inhibition of the formed kallikrein by a natural plasma inhibitor. Eur J Immunol. 1972 Aug;2(4):345–349. doi: 10.1002/eji.1830020409. [DOI] [PubMed] [Google Scholar]
  31. Tokaji G. The chemical pathology of thermal injury, with special reference to burns SH-dependent protease and its inhibitor. Kumamoto Med J. 1971 Jun 30;24(2):68–86. [PubMed] [Google Scholar]
  32. Udaka K., Takeuchi Y., Movat H. Z. Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med. 1970 Apr;133(4):1384–1387. doi: 10.3181/00379727-133-34695. [DOI] [PubMed] [Google Scholar]
  33. Van Leuven F., Cassiman J. J., Van den Berghe H. Functional modifications of alpha 2-macroglobulin by primary amines. I. Characterization of alpha 2 M after derivatization by methylamine and by factor XIII. J Biol Chem. 1981 Sep 10;256(17):9016–9022. [PubMed] [Google Scholar]
  34. Van Leuven F., Cassiman J. J., Van den Berghe H. Functional modifications of alpha 2-macroglobulin by primary amines. II. Inhibition of covalent binding of trypsin to alpha 2 M by methylamine and other primary amines. J Biol Chem. 1981 Sep 10;256(17):9023–9027. [PubMed] [Google Scholar]
  35. Yamamoto T., Cochrane C. G. A protease-like permeability factor in guinea pig skin: immunologic identity with plasma Hageman factor. Am J Pathol. 1982 May;107(2):127–134. [PMC free article] [PubMed] [Google Scholar]
  36. Yamamoto T., Cochrane C. G. Guinea pig Hageman factor as a vascular permeability enhancement factor. Am J Pathol. 1981 Nov;105(2):164–175. [PMC free article] [PubMed] [Google Scholar]
  37. Yamamoto T., Kambara T. A protease-like permeability factor in the guinea pig skin. 1. Partial purification and characterization. Biochim Biophys Acta. 1978 Apr 19;540(1):55–64. doi: 10.1016/0304-4165(78)90434-8. [DOI] [PubMed] [Google Scholar]
  38. Yamamoto T., Kozono K., Kambara T. A protease-like permeability factor in the guinea pig skin. 2. In vitro activation of the latent form permeability factor by weakly acidic phosphate buffer. Biochim Biophys Acta. 1978 Aug 17;542(2):222–231. doi: 10.1016/0304-4165(78)90018-1. [DOI] [PubMed] [Google Scholar]
  39. Yamamoto T., Kozono K., Okamoto T., Kato H., Kambara T. Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin. Biochim Biophys Acta. 1980 Aug 7;614(2):511–525. doi: 10.1016/0005-2744(80)90240-5. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES